{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:54:17Z","timestamp":1790398457607,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.drugalcdep.2019.06.017","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T11:37:37Z","timestamp":1567165057000},"page":"107515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Fentanyl exposure and preferences among individuals starting treatment for opioid use disorder"],"prefix":"10.1016","volume":"204","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5920-4057","authenticated-orcid":false,"given":"Jan","family":"Gryczynski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon Gwin","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulette","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Wireman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0005","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12954-015-0088-4","article-title":"Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, Canada","volume":"12","author":"Amlani","year":"2015","journal-title":"Harm. Reduct. J."},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0010","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.drugpo.2017.05.023","article-title":"Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode island: a mixed methods study","volume":"46","author":"Carroll","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0015","series-title":"Provisional Counts of Drug Overdoses","author":"CDC","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugpo.2017.06.010","article-title":"Fentanyl in the US heroin supply: a rapidly changing risk environment","volume":"46","author":"Ciccarone","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0025","first-page":"46","article-title":"Heroin uncertainties: exploring users\u2019 perceptions of fentanyl-adulterated and -substituted\u2019 heroin\u2019","author":"Ciccarone","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0030","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJMc1505541","article-title":"Shifting patterns of prescription opioid and heroin abuse in the United States","volume":"373","author":"Cicero","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0035","article-title":"Fentanyl: receptor pharmacology, abuse potential, and implications for treatment","author":"Comer","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0040","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Relationship between nonmedical prescription-opioid use and heroin use","volume":"374","author":"Compton","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0045","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.drugalcdep.2014.10.005","article-title":"Observed transition from opioid analgesic deaths toward heroin","volume":"145","author":"Dasgupta","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2017.10.020","article-title":"Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: a cross-sectional urine toxicology screening study","volume":"183","author":"Hayashi","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0055","first-page":"298","article-title":"Rapid change in fentanyl prevalence in a community-based, high-risk sample","volume":"75","author":"Jones","year":"2018","journal-title":"JAMA Psych."},{"issue":"7","key":"10.1016\/j.drugalcdep.2019.06.017_bib0060","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1001\/jama.2018.2844","article-title":"Changes in synthestic opioid involvement in drug overdose deaths in the United States, 2010-2016","volume":"319","author":"Jones","year":"2018","journal-title":"JAMA"},{"issue":"September 2017","key":"10.1016\/j.drugalcdep.2019.06.017_bib0065","article-title":"The first count of fentanyl deaths in 2016: up 540% in three years","volume":"2","author":"Katz","year":"2017","journal-title":"New York Times"},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jsat.2018.01.005","article-title":"Expected and actual fentanyl exposure among persons seeking opioid withdrawal management","volume":"86","author":"Kenney","year":"2018","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0075","first-page":"1","article-title":"A descriptive examination of nonmedical fentanyl use in the United States: characteristics of use, motivates, and consequences","author":"Kilwein","year":"2018","journal-title":"J. Drug Issues"},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.addbeh.2017.01.014","article-title":"Prevalence and correlates of fentanyl-contaminated heroin exposure among young adults who use prescription opioids non-medically","volume":"68","author":"Macmadu","year":"2017","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0085","first-page":"1","article-title":"Sold as heroin: perceptions and use of an evolving drug in Baltimore, MD","author":"Mars","year":"2017","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0090","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12954-018-0232-z","article-title":"Toots, tastes, and tester shots: user accounts of drug sampling methods for gauging heroin potency","volume":"15","author":"Mars","year":"2018","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0095","series-title":"Unintentional Drug- and Alcohol-related Intoxication Deaths in Maryland","author":"Maryland Department of Health","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.drugalcdep.2018.09.006","article-title":"Characterizing fentanyl-related overdoses and implications for overdose response: findings from a rapid ethnographic study in Vancouver, Canada","volume":"193","author":"Mayer","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0105","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.15585\/mmwr.mm6643e1","article-title":"Deaths involving fentanyl, fentanyl analogs, and U-47700 \u2014 10 states, July\u2013december 2016","author":"O\u2019Donnell","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"1","key":"10.1016\/j.drugalcdep.2019.06.017_bib0110","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/00952990.2018.1550652","article-title":"Testing hair for fentanyl exposure: A method to inform harm reudction behavior among individuals who use heroin","volume":"45","author":"Palamar","year":"2019","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0115","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/ADM.0000000000000324","article-title":"Misuse of novel synthetic opioids: a deadly new trend","volume":"11","author":"Prekupec","year":"2017","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0120","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths--United States, 2000-2014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0125","first-page":"1419","article-title":"Drug and opioid-involved overdose deaths \u2013 United States, 2013-2017","author":"Scholl","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0130","series-title":"FORECAST Study Summary Report","author":"Sherman","year":"2018"},{"issue":"1","key":"10.1016\/j.drugalcdep.2019.06.017_bib0135","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.drugalcdep.2018.07.019","article-title":"Methadone maintenance treatment among patients exposed to illicit fentanyl in Rhode Island: Safety, dose, retention, and relapse at 6 months","volume":"192","author":"Stone","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2016.11.033","article-title":"A review: Fentanyl and non-pharmaceutical fentanyls","volume":"171","author":"Suzuki","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0145","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1377\/hlthaff.2017.0260","article-title":"Opioid abuse and poisoning: trends in inpatient and emergency department discharges","volume":"36","author":"Tedesco","year":"2017","journal-title":"Health Aff. (Millwood)"},{"key":"10.1016\/j.drugalcdep.2019.06.017_bib0150","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000486","article-title":"Impact of fentanyl use on buprenorphine treatment retention and opioid abstinence","author":"Wakeman","year":"2019","journal-title":"J. Addict. Med."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619302741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619302741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:00:04Z","timestamp":1759827604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871619302741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":30,"alternative-id":["S0376871619302741"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.06.017","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fentanyl exposure and preferences among individuals starting treatment for opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107515"}}